You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
- Primary treatment of ovarian cancer in combination with a platinum agent.
- Treatment of metastatic carcinoma of the ovary after failure of standard therapy.
- Treatment of metastatic carcinoma of the breast after failure of standard therapy.
- Adjuvant treatment of node-positive breast cancer administered sequentially to doxorubicin and cyclophosphamide.
- Treatment of metastatic cancer of the breast, in combination with trastuzumab (Herceptin½), in patients who have tumours that over-express HER-2 and who have not received previous chemotherapy for their metastatic disease.
- in combination with gemcitabine (Gemzar½), is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.
- for the treatment of non-small cell lung cancer (NSCLC).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
- Primary treatment of ovarian cancer in combination with a platinum agent.. - Treatment of metastatic carcinoma of the ovary after failure of standard therapy.. - Treatment of metastatic carcinoma of the breast after failure of standard therapy.. - Adjuvant treatment of node-positive breast cancer administered sequentially to doxorubicin and cyclophosphamide.. - Treatment of metastatic cancer of the breast, in combination with trastuzumab (Herceptin½), in patients who have tumours that over-express HER-2 and who have not received previous chemotherapy for their metastatic disease.. - in combination with gemcitabine (Gemzar½), is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. . - for the treatment of non-small cell lung cancer (NSCLC).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
- Primary treatment of ovarian cancer in combination with a platinum agent.. - Treatment of metastatic carcinoma of the ovary after failure of standard therapy.. - Treatment of metastatic carcinoma of the breast after failure of standard therapy.. - Adjuvant treatment of node-positive breast cancer administered sequentially to doxorubicin and cyclophosphamide.. - Treatment of metastatic cancer of the breast, in combination with trastuzumab (Herceptin½), in patients who have tumours that over-express HER-2 and who have not received previous chemotherapy for their metastatic disease.. - in combination with gemcitabine (Gemzar½), is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. . - for the treatment of non-small cell lung cancer (NSCLC).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
